Increased risk of cardiometabolic disease in normal-weight individuals with non-alcoholic fatty liver disease

Nonalcoholic Fatty Liver Disease (NAFLD) is Independently Associated with Higher All-Cause and Cause-Specific Mortality

(2023) Leyla de Avila et al.   Clinical Gastroenterology and Hepatology

Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities

(2023) Karn Wijarnpreecha et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)

(2023) Oumarou Nabi et al.   HEPATOLOGY

Metabolically unhealthy phenotype in adults with normal weight: Is cardiometabolic health worse off when compared to adults with obesity?

(2023) Myong-Won Seo et al.   Obesity Research & Clinical Practice

Epidemiology and Prevalence of Lean Non‐Alcoholic Fatty Liver Disease and Associated Cirrhosis, HCC and Cardiovascular Outcomes in the United States: A Population‐Based Study and Review of Literature

(2022) Ashraf Almomani et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

(2022) Kiarash Riazi et al.   Lancet Gastroenterology & Hepatology

NASH/liver fibrosis prevalence and incidence of non-liver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidites: Lessons from South Korea

(2021) Jiyoon Park et al.   DIGESTIVE DISEASES

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

(2020) Qing Ye et al.   Lancet Gastroenterology & Hepatology

Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study

(2020) Michelle T. Long et al.   HEPATOLOGY

Genetics and epigenetics of NAFLD and NASH: Clinical impact

(2018) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Mechanisms of NAFLD development and therapeutic strategies

(2018) Scott L. Friedman et al.   NATURE MEDICINE

Association between body mass index and fatty liver risk: A dose-response analysis

(2018) Rui Fan et al.   Scientific Reports

The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

(2017) Shujun Zhang et al.   Lipids in Health and Disease

Estimated carotid–femoral pulse wave velocity has similar predictive value as measured carotid–femoral pulse wave velocity

(2016) Sara V. Greve et al.   JOURNAL OF HYPERTENSION

Nonalcoholic Fatty Liver Disease and Vascular Function: Cross-Sectional Analysis in the Framingham Heart Study

(2015) M. T. Long et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Relationship of sitting time and physical activity with non-alcoholic fatty liver disease

(2015) Seungho Ryu et al.   JOURNAL OF HEPATOLOGY

Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study

(2015) Cosmas Lesmana et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Pregravid Liver Enzyme Levels and Risk of Gestational Diabetes Mellitus During a Subsequent Pregnancy

(2014) Sneha B. Sridhar et al.   DIABETES CARE

Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis

(2010) David P. Macfarlane et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk

(2010) M. C. Amato et al.   DIABETES CARE

Diagnosis and Classification of Diabetes Mellitus

(2010)   DIABETES CARE

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE

Resveratrol inhibits nonalcoholic fatty liver disease in rats

(2008) Luis Bujanda et al.   BMC GASTROENTEROLOGY